{"id":"W2415117000","doi":"10.1016/j.jlr.2026.101063","title":"PCSK9 inhibition-mediated reduction in Lp(a) with evolocumab: an analysis of 10 clinical trials and the LDL receptor's role","year":2016,"lang":"en","type":"article","venue":"Journal of Lipid Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":214,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal","funders":"Regeneron Pharmaceuticals; GlaxoSmithKline; AstraZeneca; Daiichi-Sankyo; Fondation Leducq; Pfizer; Amgen; Bristol-Myers Squibb; Eisai; Sanofi; Abbott Laboratories","keywords":"Evolocumab; PCSK9; Kexin; LDL receptor; Internal medicine; Endocrinology; Lipoprotein(a); Quartile; Lipoprotein; Monoclonal antibody; Medicine; Internalization; Low-density lipoprotein; Alirocumab; Receptor; Cholesterol; Chemistry; Antibody; Immunology; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01199826,0.000989181,0.003227621,0.0006885483,0.0002594626,0.001512927,0.0005321953,0.000825737,0.001182046],"category_scores_gemma":[0.007492028,0.0005372024,0.003524296,0.001283485,0.0008185741,0.0006830765,0.0005121727,0.001170598,0.0001660363],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00104082,"about_ca_system_score_gemma":0.001221906,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004062649,"about_ca_topic_score_gemma":0.001244099,"domain_scores_codex":[0.9952284,0.00251928,0.0006672337,0.0006668192,0.000665329,0.0002529375],"domain_scores_gemma":[0.9938061,0.003129575,0.001545256,0.0004391963,0.0004741323,0.0006057846],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.5893461,0.003408543,0.07515512,0.00840681,0.05744817,0.0005026103,0.0003859336,0.00318425,0.03014563,0.0003442947,0.00199138,0.2296812],"study_design_scores_gemma":[0.2174393,0.2884496,0.3522029,0.001619242,0.09944928,0.001856848,0.0004533326,0.004132338,0.0145087,0.0007730298,0.01888858,0.0002268574],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9316105,0.06414507,0.0009137464,0.0003250621,0.00007401776,0.0009056872,0.0009428962,0.00005941729,0.001023689],"genre_scores_gemma":[0.9833425,0.01300351,0.001147141,0.0003151669,0.00008038797,0.0006405318,0.0009807514,0.00002404311,0.0004659237],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01199826,"threshold_uncertainty_score":0.06345367,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1269059781196437,"score_gpt":0.4673184434497075,"score_spread":0.3404124653300638,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}